Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
Active
Global HQ
Cambridge, United States
Countries of investment
  • United States
  • France
  • Switzerland
  • United Kingdom
  • Israel
Investment stages
  • Series B
  • Series C
Industries
  • Autoimmune Biotech
About
Vie Ventures is a biotech VC building partnerships between startups and patient foundations. It accelerates immune therapeutics with mission-aligned capital.
Min check size
$500K
Max check size
$3M
Fund size
NPS

Investment Thesis

Invests in autoimmune disease biotech companies at Series B/C stages, often alongside nonprofits.
Lead investor
Co Invest
Number of exits
Preferred contact method

Vie Ventures Contacts Information

Primary contact

Team

Amy McCart, Eric Moessinger, Brent Vaughan

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp